<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37649892</PMID><DateRevised><Year>2023</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1663-9812</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in pharmacology</Title><ISOAbbreviation>Front Pharmacol</ISOAbbreviation></Journal><ArticleTitle><i>Bryum billardieri</i> Schwaegr. against EV71 infection: <i>in vitro</i> and <i>in vivo</i> antiviral effects, identification of molecular mechanisms and active monomers.</ArticleTitle><Pagination><StartPage>1164784</StartPage><MedlinePgn>1164784</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1164784</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fphar.2023.1164784</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) commonly causes symptoms such as hand, foot, and mouth disease (HFMD) in infants and children and may lead to neurological disease and even death in severe cases. Appropriate vaccines for the prevention of HFMD are available in the clinic; however, they present different and serious adverse effects that cannot guarantee compliance and efficacy. The purpose of this study was to analyze the potential mechanism of <i>Bryum billardieri</i> Schwaegr. (BBS) against EV71 and analyze its potential active components. A previous <i>in vitro</i> antiviral assay was used to determine the best extraction method for the active site of BBS against EV71, and the results showed that the antiviral activity of BBS was more pronounced in the fraction that was extracted by aqueous extraction and alcoholic precipitation and then obtained by purification on a silica gel column (dichloromethane:methanol = 0:100). In addition, the therapeutic effects of BBS on EV71-infected mice were further investigated by <i>in vivo</i> pharmacological experiments. BBS reduced the lung index, viral titer, and degree of EV71-induced lung, brain, and skeletal muscle damage. The mechanism of anti-EV71 activity of BBS was also investigated by using ELISA and qRT-PCR, and it was found that BBS exerted its action mainly by regulating the expression of TLR3, TLR4, TNF-<i>α</i>, IL-2, and IFN-<i>γ</i> by modulating the activation of NF-<i>κ</i>B and JAK2/STAT1 signaling pathways. Finally, the chemical structures of the active monomers in BBS were determined by using UPLC-MS and NMR techniques. The study revealed that one of the monomers on which BBS exerts its antiviral activity is saponarin. In conclusion, the results of this study suggest that BBS is considered a natural anti-EV71 product with enormous potential, and saponarin would be its non-negligible active monomer.</AbstractText><CopyrightInformation>Copyright © 2023 Wang, Li, Han, Wan, Zhang, Niu, Xin and Zhou.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yun-Yu</ForeName><Initials>YY</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Shandong University of Traditional Chinese Medicine, Ji'nan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Shandong Qidu Pharmaceutical Co., Ji'nan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Xiu-Wei</ForeName><Initials>XW</Initials><AffiliationInfo><Affiliation>Zhaoyuan Inspection and Testing Center, Yantai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wan</LastName><ForeName>Xin-Huan</ForeName><Initials>XH</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Shandong University of Traditional Chinese Medicine, Ji'nan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The Fifth Affiliated Hospital of Xinjiang Medical University, Urumqi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niu</LastName><ForeName>Feng-Jv</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Shandong University of Traditional Chinese Medicine, Ji'nan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xin</LastName><ForeName>Yi-Zhou</ForeName><Initials>YZ</Initials><AffiliationInfo><Affiliation>Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Ji'nan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Chang-Zheng</ForeName><Initials>CZ</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Shandong University of Traditional Chinese Medicine, Ji'nan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pharmacol</MedlineTA><NlmUniqueID>101548923</NlmUniqueID><ISSNLinking>1663-9812</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bryum billardieri Schwaegr.</Keyword><Keyword MajorTopicYN="N">EV71</Keyword><Keyword MajorTopicYN="N">cytokines</Keyword><Keyword MajorTopicYN="N">saponarin</Keyword><Keyword MajorTopicYN="N">toll-like receptors</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>31</Day><Hour>4</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37649892</ArticleId><ArticleId IdType="pmc">PMC10463183</ArticleId><ArticleId IdType="doi">10.3389/fphar.2023.1164784</ArticleId><ArticleId IdType="pii">1164784</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Anand U., Jacobo-Herrera N., Altemimi A., Lakhssassi N. (2019). A comprehensive review on medicinal plants as antimicrobial therapeutics: potential avenues of biocompatible drug discovery. Metabolites 9 (11), 258. 10.3390/metabo9110258</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo9110258</ArticleId><ArticleId IdType="pmc">PMC6918160</ArticleId><ArticleId IdType="pubmed">31683833</ArticleId></ArticleIdList></Reference><Reference><Citation>Asakawa Y., Ludwiczuk A., Nagashima F., Toyota M., Hashimoto T., Tori M., et al. (2009). Bryophytes: bio- and chemical diversity, bioactivity and chemosystematics. Heterocycles 77 (1), 99–150. 10.3987/REV-08-SR(F)3</Citation><ArticleIdList><ArticleId IdType="doi">10.3987/REV-08-SR(F)3</ArticleId></ArticleIdList></Reference><Reference><Citation>Aswathyraj S., Arunkumar G., Alidjinou E. K., Hober D. (2016). Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy. Med. Microbiol. Immun. 205 (5), 397–407. 10.1007/s00430-016-0465-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-016-0465-y</ArticleId><ArticleId IdType="pubmed">27406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Atanasov A., Waltenberger B., Pferschy-Wenzig E., Linder T., Wawrosch C., Uhrin P., et al. (2015). Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnol. Adv. 33 (8), 1582–1614. 10.1016/j.biotechadv.2015.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biotechadv.2015.08.001</ArticleId><ArticleId IdType="pmc">PMC4748402</ArticleId><ArticleId IdType="pubmed">26281720</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinkmeier E., Geiger H., Zinsmeister H. (1999). Biflavonoids and 4,2 '-epoxy-3-phenylcoumarins from the moss Mnium hornum . Phytochemistry 52 (2), 297–302. 10.1016/S0031-9422(98)00514-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0031-9422(98)00514-7</ArticleId></ArticleIdList></Reference><Reference><Citation>
Cardosa M. J., Perera D., Brown B. A., Cheon D., Chan H. M., Chan K. P., et al.  (2003). Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes. Emerg. Infect. Dis.
9 (4), 461–468. 10.3201/eid0904.020395
http://www.drplace.com/Molecular_epidemiology_of_human_enterovirus_71_strains_and_recent_outbreaks_in_the_Asia-Pacific_regi.17.9.htm
</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid0904.020395</ArticleId><ArticleId IdType="pmc">PMC2957976</ArticleId><ArticleId IdType="pubmed">12702227</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H. L., Huang J. Y., Chu T. W., Tsai T. C., Hung C. M., Lin C. C., et al. (2008). Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection. Vaccine 26 (23), 2882–2889. 10.1016/j.vaccine.2008.03.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2008.03.041</ArticleId><ArticleId IdType="pubmed">18450335</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y. J., Lin J. H., Zhao Y., Ma X. P., Yi H. S. (2021). Toll-like receptor 3 (TLR3) regulation mechanisms and roles in antiviral innate immune responses. J. Zhejiang Univ.- Sci. B 22 (8), 609–632. 10.1631/jzus.B2000808</Citation><ArticleIdList><ArticleId IdType="doi">10.1631/jzus.B2000808</ArticleId><ArticleId IdType="pmc">PMC8377577</ArticleId><ArticleId IdType="pubmed">34414698</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia M. Y., Chung W. Y., Wang C. H., Chang W. H., Lee M. S. (2018). Development of a high-growth enterovirus 71 vaccine candidate inducing cross-reactive neutralizing antibody responses. Vaccine 36 (9), 1167–1173. 10.1016/j.vaccine.2018.01.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2018.01.041</ArticleId><ArticleId IdType="pubmed">29398272</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung Y. C., Ho M. S., Wu J. C., Chen W. J., Huang J. H., Chou S. T., et al. (2008). Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal, challenge. Vaccine 26 (15), 1855–1862. 10.1016/j.vaccine.2008.01.058</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2008.01.058</ArticleId><ArticleId IdType="pubmed">18329759</ArticleId></ArticleIdList></Reference><Reference><Citation>de Crom S. C. M., Rossen J. W. A., van Furth A. M., Obihara C. C. (2016). Enterovirus and parechovirus infection in children: A brief overview. Eur. J. Pediatr. 175, 1023–1029. 10.1007/s00431-016-2725-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-016-2725-7</ArticleId><ArticleId IdType="pmc">PMC4930465</ArticleId><ArticleId IdType="pubmed">27156106</ArticleId></ArticleIdList></Reference><Reference><Citation>Dell’Annunziata F., Sellitto C., Franci G., Marcotullio M. C., Piovan A., Marca R. D., et al. (2022). Antiviral activity of Ficus rubiginosa leaf extracts against HSV-1, HCoV-229E and PV-1. Viruses 14 (10), 2257. 10.3390/v14102257</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14102257</ArticleId><ArticleId IdType="pmc">PMC9607631</ArticleId><ArticleId IdType="pubmed">36298811</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Y. Y., Chen X. G., Qian B. H., Wu G. R., He T., Feng J. J., et al. (2015). Characterization of the antibody response against EV71 capsid proteins in Chinese individuals by NEIBM-ELISA. Sci. Rep. 5, 10636. 10.1038/srep10636</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep10636</ArticleId><ArticleId IdType="pmc">PMC4448526</ArticleId><ArticleId IdType="pubmed">26023863</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichenberger W., Gfeller H., Grey P., Gribi C., Henderson R. J. (1996). Gas chromatographic mass spectrometric identification of betaine lipids in Chroomonas salina . Phytochemistry 42 (4), 967–972. 10.1016/0031-9422(96)00055-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0031-9422(96)00055-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng Z. K., Li Y. Q., Cui Q. H., Du R. K., Tian J. Z. (2019). Exploration of the mechanisms of Ge Gen Decoction against influenza A virus infection. Chin. J. Nat. Med. 17 (9), 650–662. 10.1016/S1875-5364(19)30079-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1875-5364(19)30079-2</ArticleId><ArticleId IdType="pmc">PMC7128581</ArticleId><ArticleId IdType="pubmed">31526500</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo D., Yu X. H., Wang D., Li Z. F., Zhou Y., Xu G. D., et al. (2022). SLC35B2 acts in a dual role in the host sulfation required for EV71 infection. J. Virol. 96 (9), e0204221–21. 10.1128/jvi.02042-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.02042-21</ArticleId><ArticleId IdType="pmc">PMC9093107</ArticleId><ArticleId IdType="pubmed">35420441</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo M. M., Deng L., Liang H. Y., Gao W. R., Tian N., Bi Y., et al. (2023). Development and preliminary application of a droplet digital PCR assay for quantifying the oncolytic herpes simplex virus type 1 in the clinical-grade production. Viruses 15 (1), 178. 10.3390/v15010178</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15010178</ArticleId><ArticleId IdType="pmc">PMC9867280</ArticleId><ArticleId IdType="pubmed">36680218</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahn H., Seeger T., Geiger H., Zinsmeister H. D., Markham K. R., Wong H. (1995). The first biaurone, a triflavone and biflavonoids from two Aulacomnium species. Phytochemistry 40 (2), 573–576. 10.1016/0031-9422(95)00340-D</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0031-9422(95)00340-D</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunming Institute of Botany, Chinese Academy of Sciences (2005). Yunnan botanical journal. Beijing: Science Publishers.</Citation></Reference><Reference><Citation>Li M. Y., Wang L. Y., Li S. Q., Hua C. L., Gao H., Ning D. D., et al. (2022). Chemical composition, antitumor properties, and mechanism of the essential oil from Plagiomnium acutum T. Kop. Int. J. Mol. Sci. 23 (23), 14790. 10.3390/ijms232314790</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232314790</ArticleId><ArticleId IdType="pmc">PMC9738176</ArticleId><ArticleId IdType="pubmed">36499119</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y. W., Li R. J., Yuan L. Y., Chang Y., Wang X. L., Chen L. H. (2015). Chenmical constituents from flower of Gentiana tibetica . Chin. Tradit. Herb. Drugs 46 (14), 2052–2056. 10.7501/j.issn.0253-2670.2015.14.006</Citation><ArticleIdList><ArticleId IdType="doi">10.7501/j.issn.0253-2670.2015.14.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Y. Y., Li K. W., Niu F. J., Li Y., Wei H. C., Wang Y. Y., et al. (2021). Salvia plebeia R. Br. polysaccharides (SPP) against RSV (respiratory syncytial virus) infection: antiviral effect and mechanisms of action. Biomed. Pharm. 141, 111843. 10.1016/j.biopha.2021.111843</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.111843</ArticleId><ArticleId IdType="pubmed">34175821</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Z. B. (2020). The proliferative and regenerative activities as well as mechanism of intesting crypt cells upon radiation exposure mediated by MPLA. The Second Military Medical University. 10.26998/d.cnki.gjuyu.2020.000070</Citation><ArticleIdList><ArticleId IdType="doi">10.26998/d.cnki.gjuyu.2020.000070</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin T. Y., Twu S. J., Ho M. S., Chang L. Y., Lee C. Y. (2003). Enterovirus 71 outbreaks, taiwan: occurrence and recognition. Emerg. Infect. Dis. 9 (3), 291–293. 10.3201/eid0903.020285</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid0903.020285</ArticleId><ArticleId IdType="pmc">PMC2963902</ArticleId><ArticleId IdType="pubmed">12643822</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips R. L., Wang Y., Cheon H., Kanno Y., Gadina M., Sartorelli V., et al. (2022). The JAK-STAT pathway at 30: much learned, much more to do. Cell 185 (21), 3857–3876. 10.1016/j.cell.2022.09.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.09.023</ArticleId><ArticleId IdType="pmc">PMC9815833</ArticleId><ArticleId IdType="pubmed">36240739</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P., Perera R., Cardosa J., Kuhn J. R., Rossmann G., et al. (2012). Crystal structure of human enterovirus 71. Science 336 (6086), 1274. 10.1126/science.1218713</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1218713</ArticleId><ArticleId IdType="pmc">PMC3448362</ArticleId><ArticleId IdType="pubmed">22383808</ArticleId></ArticleIdList></Reference><Reference><Citation>Puenpa J., Wanlapakorn N., Vongpunsawad S., Poovorawan Y. (2019). The history of enterovirus A71 outbreaks and molecular epidemiology in the Asia-pacific region. J. Biomed. Sci. 26 (1), 75. 10.1186/s12929-019-0573-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-019-0573-2</ArticleId><ArticleId IdType="pmc">PMC6798416</ArticleId><ArticleId IdType="pubmed">31627753</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh M., Govindarajan R., Nath V., Singh Rawat A. K., Mehrotra S. (2006). Antimicrobial, wound healing and antioxidant activity of Plagiochasma appendiculatum . Lehm. Lind. J. Ethnopharmacol 107, 67–72. 10.1016/j.jep.2006.02.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2006.02.007</ArticleId><ArticleId IdType="pubmed">16600543</ArticleId></ArticleIdList></Reference><Reference><Citation>Su R., Shereen M. A., Zeng X. F., Liang Y. C., Li W., Ruan Z. H., et al. (2020). The TLR3/IRF1/Type III IFN axis facilitates antiviral responses against enterovirus infections in the intestine. mBio 11 (6), 025400-20–e2620. 10.1128/mBio.02540-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02540-20</ArticleId><ArticleId IdType="pmc">PMC7683398</ArticleId><ArticleId IdType="pubmed">33203755</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y. F., Xu Q. H., Duan M. L. (2020). Regulatory effect of geniposide on influenza virus-induced lung injury in mice based on the TLR3/TRIF pathway. Chin. J. Virol. 36 (01), 35–43. 10.13242/j.cnki.bingduxuebao.003638</Citation><ArticleIdList><ArticleId IdType="doi">10.13242/j.cnki.bingduxuebao.003638</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F. (2020). Analysis of the effective parts of Biraeus brevis against EV71 and its mechanism of action. Shandong University of Traditional Chinese Medicine. 10.27282/d.cnki.gsdzu.2020.000403</Citation><ArticleIdList><ArticleId IdType="doi">10.27282/d.cnki.gsdzu.2020.000403</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu T. T. (2012). The role of JAK2/STAT1 signaling pathway in CVB3-induced myocarditis in mice. Wenzhou Medical University. 10.7666/d.Y2231291</Citation><ArticleIdList><ArticleId IdType="doi">10.7666/d.Y2231291</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin D. Q., Wang C. B., Zhou X., Ji S. X. (2019). Epidemiology characteristics of human coxsackievirus A16 and enterovirus 71 circulating in Linyi, China, from 2009 to 2017. Jpn. J. Infect. Dis. 71 (6), 470–473. 10.7883/yoken.JJID.2018.035</Citation><ArticleIdList><ArticleId IdType="doi">10.7883/yoken.JJID.2018.035</ArticleId><ArticleId IdType="pubmed">29962487</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C., Ku Z. Q., Liu Q. W., Wang X. L., Chen T., Ye X. H., et al. (2015). High-yield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice. Vaccine 33 (20), 2335–2341. 10.1016/j.vaccine.2015.03.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.03.034</ArticleId><ArticleId IdType="pubmed">25820068</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X. L., Zhang Y. F., Li H., Liu L. D. (2023). Hand-Foot-and-Mouth disease-associated enterovirus and the development of multivalent HFMD vaccines. Int. J. Mol. Sci. 24 (1), 169. 10.3390/ijms24010169</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24010169</ArticleId><ArticleId IdType="pmc">PMC9820767</ArticleId><ArticleId IdType="pubmed">36613612</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X. L., Tian L., Wang J., Zhang B. S., Zhang W. Y. (2022). EV71 3C protease cleaves host anti-viral factor OAS3 and enhances virus replication. Virol. Sin. 37 (3), 418–426. 10.1016/j.virs.2022.04.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virs.2022.04.013</ArticleId><ArticleId IdType="pmc">PMC9243667</ArticleId><ArticleId IdType="pubmed">35504537</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>